Search Results for: First Clinical Milestone Achieved in
Articles
October 4, 2013
SPECIAL FEATURE - Hand Held Devices: New Technologies Right the Wrongs of Earlier Devices October 4, 2013
Contributor Cindy H. Dubin highlights in this annual report that new devices are coming to market that not only address the trends of home care and a need for delivering larger doses, but are also cleaning up the spotty reputation of early stage devices.
July 20, 2013
SPECIAL FEATURE - Transdermal, Topical & Subcutaneous Drug Delivery: Extending Pipelines & Improving Self-Administration July 20, 2013
Contributor Cindy H. Dubin explores how the movement of home care and self- administration is pushing the development of this growing sector in drug delivery.
November 8, 2012
11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
August 20, 2012
8/22/2012 August 20, 2012
United Drug Acquires Leading Clinical Trials Materials Business United Drug plc recently announced it has reached an agreement to acquire...
August 5, 2012
8/8/2012 August 5, 2012
Researchers Discover New Mechanism Behind Resistance to Cancer Treatment Developing resistance to chemotherapy is a nearly universal, ultimately lethal consequence...
July 19, 2012
7/25/2012 July 19, 2012
Agile Therapeutics Raises $40 Million Agile Therapeutics recently announced it has closed a $40-million Series C financing. The round was...
June 25, 2012
6/27/2012 June 25, 2012
Hovione Reports Significant Sales Growth Hovione recently announced that the consolidated sales for the fiscal year ended March 2012 amounted...
April 18, 2012
4/25/2012 April 18, 2012
Alitair Announces Patent Allowance for Platform Delivery Technology Alitair Pharmaceuticals, Inc., a mid-stage pharmaceutical company with multiple respiratory product candidates...
April 8, 2012
4/10/2012 April 8, 2012
Catalent & BASF Join Forces to Solve Bioavailabilty Challenges Catalent Pharma Solutions and BASF recently announced they have entered into...
March 7, 2012
3/13/2012 March 7, 2012
Aegerion Pharmaceuticals Submits US & EU Marketing Applications Aegerion Pharmaceuticals, Inc. recently announced it has submitted an NDA to the...
January 22, 2012
1/24/2012 January 22, 2012
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company,...
January 22, 2012
Avila Announces Allowance of IND Application for Oral EGFR Mutant-Selective Inhibitor January 22, 2012
Avila Therapeutics, Inc. recently announced it has achieved the first milestone in its Epidermal Growth Factor Receptor (EGFR) Mutant-Selective Inhibitor...
December 4, 2011
12/6/2011 December 4, 2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
November 27, 2011
Aileron Therapeutics, Roche Expand $1.1-Billion Drug Collaboration November 27, 2011
Aileron Therapeutics recently announced that Roche will initiate a new program to expand its collaboration with Aileron to discover, develop,...
November 20, 2011
11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...
November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting November 20, 2011
Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life Science Limited Partnership, has completed a successful pre-IND meeting...
November 10, 2011
11/15/2011 November 10, 2011
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently...
October 27, 2011
11/01/2011 October 27, 2011
Activartis Develops Cancer Vaccine in Phase II, Seeks Partner Activartis GmbH (formerly Trimed Biotech GmbH) recently announced it is developing...
October 13, 2011
10/17/2011 October 13, 2011
Oncobiologics Announces Two New Agreements Worth Almost $80 Million Oncobiologics recently announced it has signed two major agreements. The first...
